文献速递胸部CT

COVID-19肺炎急性期后遗症:六个月胸部CT随访

Post-Acute Sequelae of COVID-19 Pneumonia: Six-month Chest CT Follow-up.
PubMed 文献 · Radiology · 2021-07-27

前瞻性纳入118例中重度COVID-19肺炎患者,在6个月随访时复查胸部CT,与基线CT比较。72%患者出现纤维化样改变,基线肺严重程度评分>14及定量CT良好通气肺体积≤3.75 L和≤80%对预测纤维化样改变表现优异,联合模型AUC为0.92。

要点

  • 6个月随访CT上72%患者出现纤维化样改变,42%有磨玻璃影。
  • 基线LSS>14及QCCT良好通气肺体积≤3.75 L和≤80%可预测随访纤维化样改变。
  • 男性、咳嗽、淋巴细胞增多及QCCT良好通气肺体积是纤维化样改变的显著预测因素。

核心结论

  • 6个月随访胸部CT显示72%患者有晚期后遗症,尤其是纤维化样改变;基线LSS和QCCT良好通气肺体积对预测6个月纤维化样改变表现优异(AUC>0.88)。

研究设计与样本

  • 前瞻性研究,纳入2020年3月19日至2020年5月24日期间118例中重度COVID-19肺炎患者(62例女性,平均年龄65岁±12),均有基线胸部CT并在6个月随访时复查CT;分析CT定性表现、半定量肺严重程度评分(LSS)及定量胸部CT(QCCT)良好通气肺体积;用ROC曲线检验基线LSS和QCCT预测6个月随访纤维化样改变(网状图案和/或蜂窝状)的性能;用单变量和多变量logistic回归分析预测纤维化样改变的临床和影像特征,多变量分析分别用临床参数(临床模型)、影像参数(影像模型)及两者联合(联合模型)。

关键影像表现/征象

  • 6个月随访CT上85/118(72%)患者显示纤维化样改变,49/118(42%)显示磨玻璃影。

诊断标准与关键数值

  • 基线LSS>14对预测随访纤维化样改变表现优异。
  • 基线QCCT良好通气肺体积≤3.75 L和≤80%对预测随访纤维化样改变表现优异。
  • 多变量分析AUC:临床模型0.89(95%CI:0.77,0.96),影像模型0.81(95%CI:0.68,0.9),联合模型0.92(95%CI:0.81,0.98)。

临床应用与阅片要点

  • 基线LSS>14及QCCT良好通气肺体积≤3.75 L和≤80%可用于识别6个月随访时可能出现纤维化样改变的患者。
  • 男性、咳嗽、淋巴细胞增多及QCCT良好通气肺体积是6个月纤维化样改变的显著预测因素,呈负相关(AUC 0.92)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background The long-term post-acute pulmonary sequelae of COVID-19 remain unknown. Purpose To evaluate lung injury in patients affected by COVID-19 pneumonia at the 6-month follow-up CT examination compared with the baseline chest CT examination. Materials and Methods From March 19, 2020, to May 24, 2020, patients with moderate to severe COVID-19 pneumonia who had undergone baseline chest CT were prospectively enrolled at their 6-month follow-up. The CT qualitative findings, semiquantitative Lung Severity Score (LSS), and the well-aerated lung volume at quantitative chest CT (QCCT) analysis were analyzed. The performance of the baseline LSS and QCCT findings for predicting fibrosis-like changes (reticular pattern and/or honeycombing) at the 6-month follow-up chest CT examination was tested by using receiver operating characteristic curves. Univariable and multivariable logistic regression analyses were used to test clinical and radiologic features that were predictive of fibrosis-like changes. The multivariable analysis was performed with clinical parameters alone (clinical model), radiologic parameters alone (radiologic model), and the combination of clinical and radiologic parameters (combined model). Results One hundred eighteen patients who had undergone baseline chest CT and agreed to undergo follow-up chest CT at 6 months were included in the study (62 women; mean age, 65 years ± 12 [standard deviation]). At follow-up chest CT, 85 of 118 (72%) patients showed fibrosis-like changes and 49 of 118 (42%) showed ground-glass opacities. The baseline LSS (>14) and QCCT findings (≤3.75 L and ≤80%) showed excellent performance for predicting fibrosis-like changes at follow-up chest CT. In the multivariable analysis, the areas under the curve were 0.89 (95% CI: 0.77, 0.96) for the clinical model, 0.81 (95% CI: 0.68, 0.9) for the radiologic model, and 0.92 (95% CI: 0.81, 0.98) for the combined model. Conclusion At 6-month follow-up chest CT, 72% of patients showed late sequelae, in particular fibrosis-like changes. The baseline Lung Severity Score and the well-aerated lung volume at quantitative chest CT (QCCT) analysis showed excellent performance for predicting fibrosis-like changes at the 6-month chest CT (area under the curve, >0.88). Male sex, cough, lymphocytosis, and the well-aerated lung volume at QCCT analysis were significant predictors of fibrosis-like changes at 6 months, demonstrating an inverse correlation (area under the curve, 0.92). © RSNA, 2021 See also the editorial by Wells and Devaraj in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Caruso D, Guido G, Zerunian M, et al. Post-Acute Sequelae of COVID-19 Pneumonia: Six-month Chest CT Follow-up. Radiology. 2021. PMID: 34313468. doi:10.1148/radiol.2021210834

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。